YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a YIHCF research report →
Price Chart
About the company
YiChang HEC ChangJiang Pharmaceutical Co. , Ltd. is a Chinese pharmaceutical enterprise primarily engaged in the development, manufacturing, and distribution of medicinal products.
- CEO
- Juncai Jiang
- IPO
- 2021
- Employees
- 4,618
- HQ
- Yichang, CN
Get TickerSpark's AI analysis on YIHCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $643.13M
- P/E
- 24.74
- Fwd P/E
- 0.33
- PEG
- 0.25
- P/S
- 3.22
- P/B
- 1.41
- EV/EBITDA
- 12.18
- Div Yield
- 0.00%
- Gross Margin
- 75.03%
- Op Margin
- 18.11%
- Net Margin
- 12.96%
- ROE
- 5.87%
- ROIC
- 5.16%
Latest fiscal year · YoY change
- Revenue
- $3.72B-40.8%
- Gross Profit
- $2.79B-44.0%
- Op Income
- $674.47M
- Net Income
- $482.71M-75.8%
- EPS
- $0.55-75.7%
- OCF Growth
- -94.7%
- FCF Growth
- -201.3%
- 52W High
- $0.55
- 52W Low
- $0.55
- 50D MA
- $0.55
- 200D MA
- $0.55
- Beta
- 0.11
- RSI (14)
- 0
- Avg Volume
- 139
No earnings-call transcripts are available for YIHCF yet.
- Free Float
- 62.0%
- Shares Outstanding
- 1.17B
- Float Shares
- 725.52M
Our YIHCF coverage
Recent articles, reports, and earnings notes.
No research on YIHCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate YIHCF report →